New technology enables highest levels of accuracy at immense scale, with the power to sequence more than 20,000 genomes per year.
Mumbai: Illumina, Inc., known for DNA sequencing and array-based technologies, announced the launch of the NovaSeq X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that enable faster, more powerful, and more sustainable sequencing.
Using new technology, NovaSeq X Plus can generate more than 20,000 whole genomes per year, accelerating genomic discovery and clinical insights, to understand disease and ultimately transform patient lives.
Commenting on the launch, Francis deSouza, Chief Executive Officer, Illumina, said “Innovations like NovaSeq X are at the heart of how we will transform patient lives, and this groundbreaking technology will empower researchers, scientists, and clinicians in the fight to diagnose, treat – and eventually cure – disease while making genomics more sustainable and accessible to millions more people around the world.”
Alex Aravanis, Chief Technology Officer, Illumina, said “With brand new chemistry and underlying hardware and software, along with the ability to combine genomics innovations on a single platform, NovaSeq X sets a new standard in sequencing technology, while enabling discoveries and patient outcomes we never thought possible.”
On the environmental front, NovaSeq X features 90 per cent reduction in packaging waste and weight and 50 per cent reduction in plastic usage compared to NovaSeq 6000. The enablement of ambient-temperature shipping of reagents will result in nearly 500 tons of dry ice savings per year, while significantly reducing waste streams for customers.
